Cetera Investment Advisers Regeneron Pharmaceuticals, Inc. Transaction History

Cetera Investment Advisers

  • $41.3 Billion
  • Q1 2024

A detailed history of Cetera Investment Advisers transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 9,753 shares of REGN stock, worth $10.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,753
Previous 2,102 363.99%
Holding current value
$10.4 Million
Previous $2.02 Million 364.01%
% of portfolio
0.02%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 24, 2024
BUY
$902.69 - $993.35 $6.91 Million - $7.6 Million
7,651 Added 363.99%
9,753 $9.39 Million
Q1 2024

May 14, 2024
SELL
$902.69 - $993.35 $1.53 Million - $1.68 Million
-1,696 Reduced 44.66%
2,102 $2.02 Million
Q4 2023

Feb 13, 2024
BUY
$775.18 - $881.7 $91,471 - $104,040
118 Added 3.21%
3,798 $3.34 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $78,939 - $96,258
-114 Reduced 3.0%
3,680 $3.03 Million
Q2 2023

Aug 09, 2023
BUY
$700.03 - $830.35 $63,002 - $74,731
90 Added 2.43%
3,794 $2.73 Million
Q1 2023

May 15, 2023
BUY
$680.49 - $826.97 $346,369 - $420,927
509 Added 15.93%
3,704 $3.04 Million
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $1.25 Million - $1.36 Million
1,771 Added 124.37%
3,195 $2.31 Million
Q3 2022

Nov 10, 2022
SELL
$573.97 - $724.32 $754,770 - $952,480
-1,315 Reduced 48.01%
1,424 $981,000
Q2 2022

Aug 11, 2022
SELL
$548.35 - $738.84 $154,634 - $208,352
-282 Reduced 9.33%
2,739 $1.62 Million
Q1 2022

May 13, 2022
SELL
$595.12 - $698.43 $36,897 - $43,302
-62 Reduced 2.01%
3,021 $2.11 Million
Q4 2021

Feb 14, 2022
BUY
$543.48 - $670.97 $249,457 - $307,975
459 Added 17.49%
3,083 $1.95 Million
Q3 2021

Nov 16, 2021
BUY
$574.03 - $680.96 $30,997 - $36,771
54 Added 2.1%
2,624 $1.59 Million
Q2 2021

Aug 13, 2021
SELL
$472.8 - $558.54 $89,359 - $105,564
-189 Reduced 6.85%
2,570 $1.44 Million
Q1 2021

May 17, 2021
BUY
$446.73 - $548.2 $215,770 - $264,780
483 Added 21.22%
2,759 $1.31 Million
Q4 2020

Feb 17, 2021
BUY
$478.3 - $607.98 $1.09 Million - $1.38 Million
2,276 New
2,276 $1.1 Million

Others Institutions Holding REGN

# of Institutions
1,437
Shares Held
82.1M
Call Options Held
835K
Put Options Held
1.46M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $114B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email